期刊文献+

电焊作业对工人血清去甲肾上腺素含量和乙酰胆碱酯酶活性的影响 被引量:2

Effect of welding operation on noradrenalin level and acetylcholinesterase activity in serum of workers
下载PDF
导出
摘要 以某金属结构厂65名电焊作业工人为接触组,另以不接触毒物的49名非电焊工人为对照组,采用酶联免疫吸附法(ELISA)测定血清去甲肾上腺素(NE)含量,用比色法测定血清乙酰胆碱酯酶(AChE)活性。同时检测受试者血锰浓度。结果接触组NE含量为(266.69±211.63)pg/ml,明显高于对照组〔(164.68±130.45)pg/ml〕(P<0.01);接触组AChE活性为(72.35±13.61)U/ml,明显高于对照组〔(60.50±13.00)U/ml〕(P<0.01),接触组血锰为(0.778±0.389)μmol/L,明显高于对照组〔(0.546±0.321)μmol/L〕(P<0.01)。提示电焊作业可导致工人血锰浓度增加,同时引起血清NE含量和AChE活性升高。 Sixty-five welders and 49 non-welding workers were selected as exposed group and control group, respectively. The serum noradrenalin (NE) level was determined by ELISA method, the serum acetylcholinesterase (ACHE) activity was determined by spectrometric method. Additionally, the blood manganese content, air manganese levels in working places were also determined by graphite stove atomic absorption method. The result showed that the serum NE level [ (266.69 ± 211.63) pg/ml] and ACHE activity [ (72.35± 13.61) U/ml] in welding workers were significantly higher than that of the controls [ (164.68 ± 130.45) pg/ml] and [ (60.50 ± 13.00) U/ml] respectively ( P 〈 0.01). The blood manganese content in welding workers [ (0.778 ± 0.389) μmol/L] was also significantly higher than that in the control [ (0.546 ± 0.321) μmol/L] ( P 〈 0.01 ). It is suggested that welding work may induce blood manganese content rising, sermn NE level increasing and ACHE activity enhancing.
出处 《中国工业医学杂志》 CAS 北大核心 2006年第4期220-222,共3页 Chinese Journal of Industrial Medicine
基金 武汉市科委晨光计划(项目编号:2005004045) 湖北省卫生厅医药卫生科研计划(编号:K09002)
关键词 电焊工人 去甲肾上腺素 乙酰胆碱酯酶 Welders Manganese Noradrenalin Acetylcholinesterase
  • 相关文献

参考文献6

二级参考文献31

  • 1庄碧嘉,陈月华,覃国杰.锰对雌性小鼠的生殖毒性及F_1子代的影响[J].卫生毒理学杂志,1994,8(3):140-143. 被引量:7
  • 2姜岳明,陆继培,谢佩意,马富诗,梁宏柱,张凤生.锰对接触男工神经内分泌系统影响的初探[J].铁道劳动安全卫生与环保,1996,23(2):103-105. 被引量:3
  • 3郭志彬,河北医学院学报,1990年,1卷,11期,20页
  • 4朱建华,职业医学,1989年,16卷,6期,54页
  • 5叶伟,职业医学,1986年,13卷,6期,43页
  • 6王孝媛,苏州医学院学报,1985年,1卷,10页
  • 7.劳动卫生学[M].人民卫出版社,..
  • 8Romanelli FA, et al: Pharmacol Biochem Behav. 2003; 74 (2): 411-415.
  • 9Ghelardini C, et al: Neuropharmacology, 1999; 38 (3) :339-348.
  • 10Miyakawa T, et al: J Neurosci. 2001; 21 (14): 5239-5250.

共引文献29

同被引文献15

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部